• Mon. Aug 15th, 2022

AstraZeneca-Oxford Trial COVID Vaccine Moves To Crucial Phase With $1 Billion In U.S. Backing

ByArlene Huff

May 22, 2020
The investment announced this week comes just as Oxford’s vaccine team enters a crucial phase in its human trials: expanding testing with the enrollment of more than 10,000 people, including children age 5 to 12, and people over 70.


Arlene Huff

Arlene Huff is the founding member of Golden State Online. Before that She was a general assignment reporter. A native Californian, she graduated from the University of California with a degree in medical anthropology and global health. She currently lives in Los Angeles.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *

one × 5 =